Study of Adding AMG 479 to First Line Chemotherapy in Patients With Optimally Debulked Epithelial Ovarian Cancer

NCT00718523 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
170
Enrollment
OTHER
Sponsor class

Stopped The steering committee of the TRIO014 study has taken the decision to stop the TRIO014 trial.

Conditions

Interventions

Sponsor

Translational Research in Oncology